Global Antiarrhythmic Drugs Market Size & Outlook, 2025-2030
Global antiarrhythmic drugs market, 2018-2030 (US$M)
Related Markets
Global antiarrhythmic drugs market highlights
- The global antiarrhythmic drugs market generated a revenue of USD 1,111.8 million in 2024 and is expected to reach USD 1,608.3 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 6.3% by 2030.
- In terms of segment, beta blockers accounted for a revenue of USD 412.6 million in 2024.
- Potassium Channel Blockers is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, South Korea is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 1,111.8 million |
| Market revenue in 2030 | USD 1,608.3 million |
| Growth rate | 6.3% (CAGR from 2025 to 2030) |
| Largest segment | Beta blockers |
| Fastest growing segment | Potassium Channel Blockers |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Potassium Channel Blockers, Sodium Channel Blockers, Beta Blockers, Calcium Channel Blockers, Other Drug Class |
Other key industry trends
- In terms of revenue, the North America accounted for 37.5% of the global antiarrhythmic drugs market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, South Korea is the fastest growing regional market and is projected to reach USD 25.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antiarrhythmic Drugs Market Scope
Antiarrhythmic Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Mayne Pharma Group Ltd | View profile | 160 | 1538 Main North Road, Salisbury South, Salisbury, SA, Australia, 5106 | http://www.maynepharma.com |
| Bora Pharmaceuticals | View profile | 501-1000 | Taipei, T'ai-pei, Taiwan, Asia | http://www.bora-corp.com/ |
| GlaxoSmithKline Consumer Healthcare (GSK CH India) | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://india-consumer.gsk.com/ |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global antiarrhythmic drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiarrhythmic drugs market will help companies and investors design strategic landscapes.
Beta blockers was the largest segment with a revenue share of 37.11% in 2024. Horizon Databook has segmented the Global antiarrhythmic drugs market based on potassium channel blockers, sodium channel blockers, beta blockers, calcium channel blockers, other drug class covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Antiarrhythmic Drugs Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Potassium Channel Blockers
- Calcium Channel Blockers
- Sodium Channel Blockers
- Beta Blockers
- Other Drug Class
- Global Antiarrhythmic Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Parenteral
- Other Route of Administration
- Global Antiarrhythmic Drugs Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacies
- Retail Pharmacies
- Other Distribution Channel
Reasons to subscribe to Global antiarrhythmic drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global antiarrhythmic drugs market databook
-
Our clientele includes a mix of antiarrhythmic drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global antiarrhythmic drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global antiarrhythmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global antiarrhythmic drugs market size, by regions, 2018-2030 (US$M)
Top 10 countries: Antiarrhythmic drugs market size, 2024 (US$M)
Global antiarrhythmic drugs market share, by route of administration, 2024 & 2030 (%, US$M)
Antiarrhythmic drugs market: Opportunity assessment by country
Global antiarrhythmic drugs market, by region, 2024 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
